Design Therapeutics, Inc.

Informe acción NasdaqGS:DSGN

Capitalización de mercado: US$206.2m

Design Therapeutics Dirección

Dirección controles de criterios 2/4

El CEO de Design Therapeutics' es Pratik Shah , nombrado en Aug 2023, tiene una permanencia de menos de un año. compensación anual total es $4.52M, compuesta por 7.5% salario y 92.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.23% de las acciones de la empresa, por valor de $505.41K. La antigüedad media del equipo directivo y de la junta directiva es de 2.6 años y 3.8 años, respectivamente.

Información clave

Pratik Shah

Chief Executive Officer (CEO)

US$6.3m

Compensación total

Porcentaje del salario del CEO5.7%
Permanencia del CEOless than a year
Participación del CEO0.2%
Permanencia media de la dirección2.7yrs
Promedio de permanencia en la Junta Directiva3.8yrs

Actualizaciones recientes de la dirección

Recent updates

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Mar 15
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Nov 16
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Jun 06
Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Feb 09
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Oct 25
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Design Therapeutics GAAP EPS of -$0.27 misses by $0.02

Aug 08

We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate

Jul 02
We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Mar 18
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Dec 03
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Aug 18
Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Design Therapeutics expands board of directors

Jun 07

Design Therapeutics EPS misses by $0.24

May 10

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Pratik Shah en comparación con los beneficios de Design Therapeutics?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023US$6mUS$361k

-US$67m

Sep 30 2023n/an/a

-US$72m

Jun 30 2023n/an/a

-US$74m

Mar 31 2023n/an/a

-US$69m

Dec 31 2022US$5mUS$338k

-US$63m

Sep 30 2022n/an/a

-US$57m

Jun 30 2022n/an/a

-US$51m

Mar 31 2022n/an/a

-US$43m

Dec 31 2021US$585kUS$310k

-US$36m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$19m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020US$400kUS$250k

-US$8m

Compensación vs. Mercado: La compensación total de Pratik($USD4.52M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD1.60M).

Compensación vs. Ingresos: La compensación de Pratik ha aumentado mientras la empresa no es rentable.


CEO

Pratik Shah (53 yo)

less than a year

Permanencia

US$6,317,780

Compensación

Dr. Pratik Shah, Ph D., is an Executive Chairperson at Design Therapeutics, Inc. since December 2017 and serves as its President, Chief Executive Officer and Principal Financial Officer since August 25, 20...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Pratik Shah
Co-Founderless than a yearUS$6.32m0.23%
$ 474.2k
Sean Jeffries
Chief Operating Officer3.3yrsUS$1.28m1.44%
$ 3.0m
Aseem Ansari
Co-Founder & Scientific Advisorno datasin datos13.57%
$ 28.0m
Julie Burgess
Chief Accounting Officer2.7yrssin datossin datos
Jae Kim
Chief Medical Officer2.3yrssin datos0.0084%
$ 17.4k
Dawn Giangiulio
Controller4.1yrssin datossin datos

2.7yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de DSGN se considera experimentado (2.6 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Pratik Shah
Co-Founder6.4yrsUS$6.32m0.23%
$ 474.2k
Aseem Ansari
Co-Founder & Scientific Advisorno datasin datos13.57%
$ 28.0m
John Schmid
Independent Director3.5yrsUS$106.70k0.10%
$ 210.4k
Rodney Lappe
Independent Director4.8yrsUS$228.56k0.24%
$ 485.5k
Simeon George
Lead Independent Director4.3yrsUS$95.70k0%
$ 0
Deepa Prasad
Independent Director2.9yrsUS$94.20k0.042%
$ 86.9k
Heather Berger
Independent Director2.9yrsUS$94.20k0.0023%
$ 4.7k
Arsani William
Independent Director3.3yrsUS$104.20k0%
$ 0
Xiaoxing Xu
Independent Director4.2yrsUS$94.20k0.018%
$ 36.5k

3.8yrs

Permanencia media

49.5yo

Promedio de edad

Junta con experiencia: La junta directiva de DSGN se considera experimentada (3.8 años de antigüedad promedio).